ADALIMUMAB-AATY for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 80 adverse event reports in the FDA FAERS database where ADALIMUMAB-AATY was used for Psoriasis.
Most Reported Side Effects for ADALIMUMAB-AATY
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Intentional dose omission | 338 | 20.1% | 7 | 112 |
| Drug ineffective | 151 | 9.0% | 1 | 16 |
| Intentional product use issue | 151 | 9.0% | 8 | 29 |
| Death | 132 | 7.9% | 131 | 10 |
| Arthralgia | 96 | 5.7% | 2 | 15 |
| Rheumatoid arthritis | 94 | 5.6% | 5 | 7 |
| Fatigue | 92 | 5.5% | 3 | 14 |
| Therapy interrupted | 88 | 5.2% | 0 | 19 |
| Crohn's disease | 87 | 5.2% | 3 | 20 |
| Headache | 86 | 5.1% | 3 | 13 |
| Accidental exposure to product | 85 | 5.1% | 2 | 3 |
| Exposure via skin contact | 85 | 5.1% | 3 | 3 |
| Condition aggravated | 81 | 4.8% | 6 | 24 |
| Device malfunction | 80 | 4.8% | 1 | 2 |
| Nausea | 76 | 4.5% | 0 | 11 |
Other Indications for ADALIMUMAB-AATY
Rheumatoid arthritis (477)
Crohn's disease (320)
Psoriatic arthropathy (199)
Ankylosing spondylitis (147)
Product used for unknown indication (144)
Colitis ulcerative (122)
Hidradenitis (101)
Axial spondyloarthritis (22)
Uveitis (18)
Juvenile idiopathic arthritis (15)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)